These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34398237)

  • 1. Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.
    Hearps AC; Angelovich TA; Trevillyan JM; Wong ME; Calmy A; Hoy JF; Jaworowski A
    J Infect Dis; 2021 Aug; 224(4):667-672. PubMed ID: 34398237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
    Eckard AR; Jiang Y; Debanne SM; Funderburg NT; McComsey GA
    J Infect Dis; 2014 Apr; 209(8):1156-64. PubMed ID: 24415784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.
    Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA
    HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.
    Hileman CO; Dirajlal-Fargo S; Lam SK; Kumar J; Lacher C; Combs GF; McComsey GA
    J Nutr; 2015 Oct; 145(10):2293-9. PubMed ID: 26269240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
    Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
    Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.
    Erlandson KM; Jiang Y; Debanne SM; McComsey GA
    Clin Infect Dis; 2015 Nov; 61(10):1566-72. PubMed ID: 26157049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.
    Erlandson KM; Jiang Y; Debanne SM; McComsey GA
    AIDS; 2015 Jan; 29(2):175-82. PubMed ID: 25396266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin effect on coronary calcium distribution, mass and volume scores and associations with immune activation among HIV+ persons on antiretroviral therapy.
    Lipinski J; Margevicius S; Schluchter MD; Wilson DL; McComsey GA; Longenecker CT
    Antivir Ther; 2020; 25(8):419-427. PubMed ID: 33901017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
    Longenecker CT; Hileman CO; Funderburg NT; McComsey GA
    Clin Infect Dis; 2014 Oct; 59(8):1148-56. PubMed ID: 25015912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
    Garg N; Krishan P; Syngle A
    Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk.
    Vavlukis A; Vavlukis M; Dimovski A; Petrushevska G; Eftimov A; Domazetovska S; Mladenovska K
    Acta Pharm; 2022 Jun; 72(2):303-315. PubMed ID: 36651514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group IIA Secretory Phospholipase A
    Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Exercise Training and Statin Use in People Living with Human Immunodeficiency Virus with Dyslipidemia.
    Zanetti HR; Gonçalves A; Teixeira Paranhos Lopes L; Mendes EL; Roever L; Silva-Vergara ML; Neves FF; Resende ES
    Med Sci Sports Exerc; 2020 Jan; 52(1):16-24. PubMed ID: 31834252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive Statin Therapy Compromises the Adiponectin-AdipoR Pathway in the Human Monocyte-Macrophage Lineage.
    Gasbarrino K; Hafiane A; Zheng H; Daskalopoulou SS
    Stroke; 2019 Dec; 50(12):3609-3617. PubMed ID: 31648632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of statin on arginine metabolites in treated HIV-infection.
    Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
    Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.
    Pais P; Jung H; Dans A; Zhu J; Liu L; Kamath D; Bosch J; Lonn E; Yusuf S
    Eur J Prev Cardiol; 2019 May; 26(7):681-697. PubMed ID: 30537846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions.
    Fitch KV; Fulda ES; Grinspoon SK
    Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
    Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
    Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.